FEBRUARY 2023LIFE SCIENCES REVIEW6Despite the advancement of medical science, there are still many unmet therapeutic needs. Developing new drugs against novel targets or agents with greater selectivity for existing targets will improve the therapeutic options. New drug administration approaches could improve clinical outcomes and patients' quality of life.Technology-based evaluations and interventions can improve a clinician's work with clients. Additionally, technology allows alternative models of care to be offered to clients with specific needs that limit their ability to participate in more conventional interventions targeting behavioral health. Technology-assisted care (TAC) can transcend geographic boundaries to reach many people otherwise unable to access services and is helpful in a wide variety of settings, including web-based interventions offered in the home, community organizations, schools, emergency rooms, and healthcare providers' offices, as well as via mobile devices and online social networks. Furthermore, TAC is often accessible on demand at the users' convenience, thus reducing barriers to accessing care.The main costs associated with technology-based therapeutic tools involve keeping up with the latest research, training new staff members, and evaluating effectiveness. There are deployment costs, including bandwidth for online access, technical support, licensing technology, and ongoing equipment maintenance. Thus, technology-based assessment and intervention tools may be cost-effective and beneficial for many resource-constrained service settings. Overall, TAC holds great potential to impact public health.In this edition, we aim to provide our readers with insight into the current therapeutics space and the innovations in this sector.Let us know your thoughts.EDITORIALTechnology Based Interventions in the Therapeutics SpaceCopyright © 2023 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com FEBRUARY - 16 - 2023, Vol 04, Issue - 02 (ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasCatalina Joseph Clara MatthewVisualizersRonald DonovanDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsVictor Cruz
< Page 5 | Page 7 >